Market News AIOpen the app

BLTE stock news · Belite Bio

Stories about Belite Bio (BLTE) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for BLTE

Follow Belite Bio (BLTE) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for BLTE
Free on the App Store and Google Play, or on the web.
  1. Nov 13, 2026, 2:18 PM ET · Results

    Mizuho raised its price target for Belite Bio to $230 from $221 after the company’s third-quarter earnings report.

    Good for BLTE

    Mizuho raised its BLTE target from $221 to $230 and kept its favorable rating. This analyst view is positive for Belite Bio, but reports no new company results.